S100A4 Over-Expression Underlies Lymph Node Metastasis and Poor Prognosis in Colorectal Cancer

Li-Yong Huang,Ye Xu,Guo-Xiang Cai,Zu-Qing Guan,Wei-Qi Sheng,Hong-Fen Lu,Li-Qi Xie,Hao-Jie Lu,San-Jun Cai
DOI: https://doi.org/10.3748/wjg.v17.i1.69
2011-01-01
Abstract:AIM:To develop lymph node metastasis (LNM)-associated biomarkers for colorectal cancer (CRC) using quantitative proteome analysis. METHODS:Differences in protein expression between primary CRC with LNM (LNM CRC) and without LNM (non-LNM CRC) were assessed using methyl esterification stable isotope labeling coupled with 2D liquid chromatography followed by tandem mass spectrometry (2D-LC-MS/MS).The relationship to clinicopatholog-ical parameters and prognosis of candidate biomarkers was examined using an independent sample set. RESULTS:Forty-three proteins were found to be differentially expressed by at least 2.5-fold in two types of CRC.S100A4 was significantly upregulated in LNM CRC compared with non-LNM CRC, which was confirmed by Western blotting, immunohistochemistry and real-time quantitative polymerase chain reaction.Further immunohistochemistry on another 112 CRC cases showed that overexpression of S100A4 frequently existed in LNM CRC compared with non-LNM CRC (P < 0.001).Overexpression of S100A4 was significantly associated with LNM (P < 0.001), advanced TNM stage (P < 0.001), increased 5-year recurrence rate (P < 0.001) and decreased 5-year overall survival rate (P < 0.001).Univariate and multivariate analyses indicated that S100A4 expression was an independent prognostic factor for recurrence and survival of CRC patients (P < 0.05).CONCLUSION: S100A4 might serve as a powerful biomarker for LNM and a prognostic factor in CRC.
What problem does this paper attempt to address?